Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer ; volume:25 ; number:1 ; day:15 ; month:11 ; year:2023 ; pages:1-12 ; date:12.2023
Breast cancer research ; 25, Heft 1 (15.11.2023), 1-12, 12.2023
- Creator
-
Verschoor, Noortje
Smid, Marcel
Jager, Agnes
Sleijfer, Stefan
Wilting, Saskia M.
Martens, John W. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-023-01743-z
- URN
-
urn:nbn:de:101:1-2024013112012223188127
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Verschoor, Noortje
- Smid, Marcel
- Jager, Agnes
- Sleijfer, Stefan
- Wilting, Saskia M.
- Martens, John W. M.
- SpringerLink (Online service)
Other Objects (12)
Transcriptome and genome evolution during HER2-amplified breast neoplasia
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
Pan-cancer whole-genome analyses of metastatic solid tumours
Assessing the utility of whole-genome amplified serum DNA for array-based high throughput genotyping
Whole-genome sequence analysis of Zika virus, amplified from urine of traveler from the Philippines
Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
Transcriptome and genome evolution during HER2-amplified breast neoplasia
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
Pan-cancer whole-genome analyses of metastatic solid tumours
Assessing the utility of whole-genome amplified serum DNA for array-based high throughput genotyping
Whole-genome sequence analysis of Zika virus, amplified from urine of traveler from the Philippines
Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
Transcriptome and genome evolution during HER2-amplified breast neoplasia
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
Pan-cancer whole-genome analyses of metastatic solid tumours
Assessing the utility of whole-genome amplified serum DNA for array-based high throughput genotyping
Whole-genome sequence analysis of Zika virus, amplified from urine of traveler from the Philippines
Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas
Targeted therapies for ER+/HER2- metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer